About Althea Technologies
Althea Technologies is a company based in San Diego (United States) founded in 1998 by Francois Ferre was acquired by Ajinomoto in March 2013. Althea Technologies has raised $23 million across 1 funding round from investors including Ajinomoto and Telegraph Hill Partners. Althea Technologies offers products and services including Smålån Service, Forbrukslån Service, and Refinansiering Service. Althea Technologies operates in a competitive market with competitors including Suanfarma, Enzene Biosciences, Hybio Pharmaceutical, Nephron Pharmaceuticals and Kardigan, among others.
- Headquarter San Diego, United States
- Founders Francois Ferre
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Althea Technologies
Althea Technologies offers a comprehensive portfolio of products and services, including Smålån Service, Forbrukslån Service, and Refinansiering Service.
Provides information on small unsecured loans up to 70,000 kroner
Offers guidance on consumer loans for various personal needs
Advises on consolidating debts for better interest rates
Funding Insights of Althea Technologies
Althea Technologies has successfully raised a total of $23M through 1 strategic funding round. The most recent funding activity was a Series C round of $23 million completed in January 2007. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Althea Technologies
Althea Technologies has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Ajinomoto and Telegraph Hill Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on life science, medical device and healthcare companies
|
Locked | Locked | Locked | |
|
Multi-category food and beverage products are manufactured globally.
|
Locked | Locked | Locked |
Investor details for Althea Technologies
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Althea Technologies
Investment portfolio details for Althea Technologies
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Althea Technologies
Detailed financials for Althea Technologies
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Althea Technologies Comparisons
Peer comparison for Althea Technologies
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Althea Technologies
Althea Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Suanfarma, Enzene Biosciences, Hybio Pharmaceutical, Nephron Pharmaceuticals and Kardigan, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Generics, nutraceuticals, and APIs are developed by Suanfarma.
|
|
| Locked | Locked | Locked |
Company specializing in development of Biosimilars
|
|
| Locked | Locked | Locked |
Polypeptide drugs and APIs are developed and manufactured.
|
|
| Locked | Locked | Locked |
Sterile pharmaceutical products are manufactured and contract services are provided.
|
|
| Locked | Locked | Locked |
Biotech company developing personalized medicines for cardiovascular diseases
|
|
| Locked | Locked | Locked |
APIs and finished dosage forms are developed and manufactured.
|
Detailed competitors of Althea Technologies
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Althea Technologies
Complete news archive for Althea Technologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Althea Technologies
Althea Technologies was founded in 1998 and raised its 1st funding round 9 years after it was founded.
Althea Technologies is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Francois Ferre is the current CEO of Althea Technologies. They have also founded this company.
Althea Technologies is a funded company, having raised a total of $23M across 1 funding round to date.
Althea Technologies was founded in 1998 in San Diego, United States, and operates in the pharmaceutical sector as a contract manufacturer and distributor of clinical drugs and vaccines. Services provided include aseptic syringe filling, lyophilization, release testing, clinical packaging, and stability programs, supporting various clinical needs in the industry.
Althea Technologies's top competitors include Nephron Pharmaceuticals, Suanfarma and Enzene Biosciences.
Althea Technologies offers Smålån Service, Forbrukslån Service, and Refinansiering Service.
Althea Technologies has 2 investors. Key investors include Ajinomoto, and Telegraph Hill Partners.